Armata Pharmaceuticals (ARMP) Price to Book (2013 - 2026)

Armata Pharmaceuticals has disclosed Price to Book across 14 years of filings, most recently posting 1.04 for Q2 2026.

• In Q2 2026, Price to Book fell 5.24% year-over-year to 1.04; the TTM figure through Jun 2026 stood at 1.04 (down 5.24% YoY), while the FY2025 annual figure was 1.05, up 24.92% from the prior year.
• Price to Book came in at 1.04 for Q2 2026 at Armata Pharmaceuticals, up from 1.2 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 3.35 in Q3 2022 to a low of 8.75 in Q3 2023.
• Average Price to Book over 5 years is 0.69, with a median of 1.04 recorded in 2025.
• Year-over-year, Price to Book tumbled 393.83% in 2023 and jumped 80.77% in 2024.
• Over 5 years, Price to Book stood at 1.24 in 2022, then plunged by 393.83% to 3.65 in 2023, then surged by 61.81% to 1.39 in 2024, then grew by 24.92% to 1.05 in 2025, then advanced by 0.52% to 1.04 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 1.04 in Q2 2026, 1.2 in Q1 2026, and 1.05 in Q4 2025.